As a pioneering oral solution in the realm of diabetes management, Rybelsus represents a significant advancement in the ease and convenience of treatment for many patients struggling with daily injections
Obese patients are at more risk of coming with complications including high blood pressure, type two diabetes, high cholesterol levels, stroke, and certain types of cancer
When used concomitantly with insulin, the two products should be administered as separate injections and never mixed, though they can be injected in the same body region if not adjacent to each other
The fixed maintenance-dose regimen used in routine practice may have influenced tolerability
It is important to note, however, that the data summarized here include only preclinical studies